Access Resources
3711 - 3720 of 7540 Results
Title
Year
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 8
-
RESTRICTEDTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28220Citation Count: 26
- The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease2020RESTRICTEDTitle: The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01874-2Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-020-01874-2Citation Count: 9
-
RESTRICTEDTitle: 5Qs: An Activity to Support Students Develop Skills to Interpret Research ObservationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.25334/ygq4-5977Citation Count: 0
- A Letter to a Young Scientist: Prompting Students To Reflect On And Recognize Their Own Growth As Scientists2020RESTRICTEDTitle: A Letter to a Young Scientist: Prompting Students To Reflect On And Recognize Their Own Growth As ScientistsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.25334/cbp1-t733Citation Count: 0
- ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodies2020RESTRICTEDTitle: ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 4Start Page: 449End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02199-7Best OA location URL: https://europepmc.org/articles/pmc7864557?pdf=renderCitation Count: 8
-
RESTRICTED
-
RESTRICTEDTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/156468/1/mds28130_am.pdfCitation Count: 4
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies2020RESTRICTEDTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719613Citation Count: 79
- BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer2020RESTRICTEDTitle: BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerJournal Name: Lung CancerPublisher: Elsevier BVVol: 146Issue #:Start Page: 78End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.lungcan.2020.05.018Citation Count: 25